AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21943084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy self management programme administered by a clinical psychologist over six consecutive weekly sessions (2 hours each)
Number of subjects: 0
Study 21943084 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (atypical analgesia and local anaesthetic injections)
Number of subjects: 0
Study 21943084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy self management programme
Number of subjects: 0
Study 21943084 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 19068785 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates (alendronate, risedronate) and raloxifene (selective estrogen receptor modulator)
Number of subjects: 0
Study 19068785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy based on fracture risk factors
Number of subjects: 0
Study 19068785 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment for glucocorticoid- and diabetes mellitus-induced osteoporosis
Number of subjects: 0
Study 16567393 — intervention group
Group type: COMPARATOR
Intervention: Cord clamping within the first 15 seconds (group 1)
Number of subjects: 276
Study 16567393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord clamping at 1 minute (group 2)
Number of subjects: 276
Study 16567393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord clamping at 3 minutes (group 3)
Number of subjects: 276
Study 12606904 — intervention group
Group type: EXPERIMENTAL
Intervention: Approximate entropy
Number of subjects: 20
Study 12606904 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral index
Number of subjects: 20
Study 12606904 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral edge frequency 95 (SEF95)
Number of subjects: 20
Study 12606904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of drug concentrations (propofol and remifentanil)
Number of subjects: 20
Study 12606904 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerance of airway manipulation
Number of subjects: 20
Study 10575642 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis using nonbuffered electrode at 80 mA/min
Number of subjects: 60
Study 10575642 — intervention group
Group type: COMPARATOR
Intervention: Iontophoresis using buffered electrodes (preloaded immobile resins or simple phosphates)
Number of subjects: 60
Study 10575642 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis using nonbuffered electrode at 20 and 40 mA/min
Number of subjects: 60
Study 8708127 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloral hydrate 50 mg/kg with hydroxyzine 25 mg (Group 1)
Number of subjects: 0
Study 8708127 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.5 mg/kg with acetaminophen elixir 10 mg/kg (Group 2)
Number of subjects: 0
Study 1764770 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic lens (Bufilcon A)
Number of subjects: 10
Study 1764770 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic lens (Tetrafilcon A)
Number of subjects: 10
Study 1764770 — intervention group
Group type: COMPARATOR
Intervention: Control HEMA lens
Number of subjects: 10
Study 1764770 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant cleaning
Number of subjects: 10
Study 6761238 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic steroids
Number of subjects: 0
Study 6761238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31549861 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (n = 46)
Number of subjects: 91
Study 31549861 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 91
Study 31549861 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participants (experimental + control = 91)
Number of subjects: 91
Study 31481017 — intervention group
Group type: EXPERIMENTAL
Intervention: BATHE technique used by GPs during consultations
Number of subjects: 577
Study 31481017 — intervention group
Group type: EXPERIMENTAL
Intervention: BATHE technique
Number of subjects: 577
Study 28121797 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate feeding (IF) with CHO + PRO (1.5 g·kg BM dextrose and 0.5 g·kg BM whey) ingested immediately postexercise.
Number of subjects: 10
Study 28121797 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed feeding (DF) with PLA ingested immediately postexercise and CHO + PRO solution 2 h postexercise.
Number of subjects: 10
Study 28121797 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) solution ingested immediately and 2 h postexercise.
Number of subjects: 10
Study 26936134 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/low-salt (0.02% fat, 0.06% NaCl)
Number of subjects: 48
Study 26936134 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/high-salt (0.5% NaCl)
Number of subjects: 48
Study 26936134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat/low-salt (34% fat)
Number of subjects: 48
Study 26936134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat/high-salt
Number of subjects: 48
Study 26936134 — intervention group
Group type: COMPARATOR
Intervention: Low salt
Number of subjects: 48
Study 24979556 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (combination)
Number of subjects: 108
Study 24979556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 22869486 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with remifentanil (group MR)
Number of subjects: 60
Study 22869486 — intervention group
Group type: COMPARATOR
Intervention: Midazolam alone (group M)
Number of subjects: 60
Study 19233930 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L-Pop (3M Espe)
Number of subjects: 96
Study 19233930 — intervention group
Group type: EXPERIMENTAL
Intervention: Futurabond NR (Voco)
Number of subjects: 96
Study 19233930 — intervention group
Group type: EXPERIMENTAL
Intervention: Transbond Plus (3M Unitek)
Number of subjects: 96
Study 19233930 — intervention group
Group type: COMPARATOR
Intervention: Conventional acid etching system Etch-Rite (Pulpdent Corp.)
Number of subjects: 96
Study 17768467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium Bromide 1 mg/kg
Number of subjects: 60
Study 17768467 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg
Number of subjects: 60
Study 15673635 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress-writing group (n = 41)
Number of subjects: 137
Study 15673635 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-writing group (n = 37)
Number of subjects: 137
Study 15673635 — intervention group
Group type: COMPARATOR
Intervention: Control group (neutral experiences, n = 36)
Number of subjects: 137
Study 11902852 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 a Day Achievement Badge program
Number of subjects: 0
Study 11902852 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the program later)
Number of subjects: 0
Study 9598008 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal lidocaine
Number of subjects: 19
Study 9598008 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal lidocaine (5%)
Number of subjects: 19
Study 9598008 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine in nonliposomal vehicles
Number of subjects: 19
Study 9598008 — intervention group
Group type: COMPARATOR
Intervention: EMLA
Number of subjects: 19
Study 7938127 — intervention group
Group type: COMPARATOR
Intervention: Marihuana (0.004% placebo)
Number of subjects: 5
Study 7938127 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana (1.24% THC)
Number of subjects: 5
Study 7938127 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana (2.64% THC)
Number of subjects: 5
Study 7938127 — intervention group
Group type: EXPERIMENTAL
Intervention: Marihuana pretreatment
Number of subjects: 5
Study 3220095 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 12
Study 3220095 — intervention group
Group type: EXPERIMENTAL
Intervention: Adinazolam plus Cimetidine
Number of subjects: 12
Study 3220095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31764782 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huayu Jiedu decoction (YHJD) combined with chemotherapy
Number of subjects: 489
Study 31764782 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 489
Study 28107372 — intervention group
Group type: EXPERIMENTAL
Intervention: Podiatry intervention including foot and ankle exercises, foot orthoses, new footwear if required, and a falls prevention leaflet
Number of subjects: 1010
Study 28107372 — intervention group
Group type: EXPERIMENTAL
Intervention: Podiatry intervention
Number of subjects: 1010
Study 28107372 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 1010
Study 25888414 — intervention group
Group type: EXPERIMENTAL
Intervention: beta‐guanidinopropionic acid 100 mg
Number of subjects: 24
Study 25888414 — intervention group
Group type: COMPARATOR
Intervention: creatine 5 gram
Number of subjects: 24
Study 25888414 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 24499111 — intervention group
Group type: EXPERIMENTAL
Intervention: Running suture closure
Number of subjects: 460
Study 24499111 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay mesh closure
Number of subjects: 460
Study 24499111 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublay mesh closure
Number of subjects: 460
Study 21145085 — intervention group
Group type: EXPERIMENTAL
Intervention: Containment elastic orthosis and manual lymphatic drainage
Number of subjects: 48
Study 21145085 — intervention group
Group type: COMPARATOR
Intervention: Postural measures
Number of subjects: 48
Study 19393844 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 331
Study 19393844 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 331
Study 17263761 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg/day)
Number of subjects: 30
Study 17263761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 14970817 — intervention group
Group type: EXPERIMENTAL
Intervention: L5 spinous hook adjustment
Number of subjects: 30
Study 14970817 — intervention group
Group type: COMPARATOR
Intervention: Lower sacroiliac adjustment
Number of subjects: 30
Study 11761821 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone (400 mg)
Number of subjects: 99
Study 11761821 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 or 10 mg)
Number of subjects: 99
Study 11761821 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (24 mg)
Number of subjects: 99
Study 11761821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 9418312 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpleural block with 0.4 ml/kg bupivacaine, 0.5% before induction of general anesthesia, followed by continuous administration of bupivacaine 0.25%, 0.125 ml/kg/hr.
Number of subjects: 30
Study 9418312 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (control group).
Number of subjects: 30
Study 8357472 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (120 mg)
Number of subjects: 193
Study 8357472 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine (10 mg)
Number of subjects: 193
Study 8357472 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 193
Study 8357472 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 193
Study 3306380 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg nightly for 7 to 10 nights (abrupt-withdrawal group)
Number of subjects: 60
Study 3306380 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered-dosage of triazolam: 0.5 mg for 7 nights, 0.25 mg for 2 nights, 0.125 mg for 2 nights (tapered-dosage group)
Number of subjects: 60
Study 3306380 — intervention group
Group type: COMPARATOR
Intervention: Placebo (initial treatment for both groups)
Number of subjects: 60
Study 2508417 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptive containing ethinylestradiol and gestodene
Number of subjects: 19
Study 2508417 — intervention group
Group type: COMPARATOR
Intervention: Triphasic oral contraceptive containing ethinylestradiol and levonorgestrel
Number of subjects: 19
Study 31562800 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus veliparib followed by veliparib maintenance (veliparib throughout)
Number of subjects: 1140
Study 31562800 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus veliparib followed by placebo maintenance (veliparib combination only)
Number of subjects: 1140
Study 31562800 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy plus placebo followed by placebo maintenance (control)
Number of subjects: 1140
Study 31562800 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus veliparib
Number of subjects: 1140
Study 28526486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl transdermal patches (50 μg hour−1)
Number of subjects: 24
Study 28526486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl transdermal patches (75 μg hour−1)
Number of subjects: 24
Study 28526486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl transdermal patches (100 μg hour−1)
Number of subjects: 24
Study 28526486 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patches (35 μg hour−1)
Number of subjects: 24
Study 28526486 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal patches (70 μg hour−1)
Number of subjects: 24
Study 25835218 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 40
Study 25835218 — intervention group
Group type: COMPARATOR
Intervention: Simulation plus workshop
Number of subjects: 40
Study 23934680 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 36
Study 23934680 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet-fructose
Number of subjects: 36
Study 21272992 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical administration of hyaluronic acid (HA) and chondroitin sulphate (CS)
Number of subjects: 57
Study 21272992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 19860245 — intervention group
Group type: EXPERIMENTAL
Intervention: BONFILS Retromolar Intubation Fiberscope (B-scope)
Number of subjects: 50
Study 19860245 — intervention group
Group type: COMPARATOR
Intervention: StyletScope (S-scope)
Number of subjects: 50
Study 16499643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 100 microg/day per nostril
Number of subjects: 56
Study 16499643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 15639693 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine TES 35 microg/h
Number of subjects: 137
Study 15639693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 11518093 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-mg nicotine patch (16-hr)
Number of subjects: 0
Study 11518093 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study 9140155 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunoileostomy
Number of subjects: 60
Study 8424910 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA)
Number of subjects: 73
Study 8424910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 3115389 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable strontium absorption test with standard breakfast
Number of subjects: 72
Study 3115389 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable strontium absorption test
Number of subjects: 72
Study 3115389 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable strontium absorption test with food
Number of subjects: 72
Study 29953026 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser therapy (wavelength: 780 nm; fluence: 134 J/cm; power: 50 mW; irradiance: 1.675 W/cm; exposure time: 80 seconds per point) on 3 points of the masseter and 1 point on the anterior temporal muscles on each side
Number of subjects: 78
Study 29953026 — intervention group
Group type: COMPARATOR
Intervention: Sham laser (placebo effect)
Number of subjects: 78
Study 29953026 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 78
Study 26749451 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol (0.25 μg daily for six months)
Number of subjects: 28
Study 26749451 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 28
Study 24509504 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-ecological intervention promoting physical activity and limiting sedentary behavior
Number of subjects: 732
Study 23422606 — intervention group
Group type: COMPARATOR
Intervention: Preparation of 2/3 (10.6 mm) of the total root length (G1 - control)
Number of subjects: 36
Study 23422606 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation of 1/2 (8 mm) of the total root length (G2)
Number of subjects: 36
Study 23422606 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation of 1/3 (5.3 mm) of the total root length (G3)
Number of subjects: 36
Study 20177860 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized 200 ml of clear carbohydrate‐enriched drink orally 2 hours before surgery
Number of subjects: 110
Study 20177860 — intervention group
Group type: COMPARATOR
Intervention: No preoperative feeding (control group)
Number of subjects: 110
Study 17233286 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity signal changes on T2-weighted MR imaging
Number of subjects: 67
Study 17233286 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity signal changes on T1-weighted MR imaging
Number of subjects: 67
Study 17233286 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-weighted MR imaging
Number of subjects: 67
Study 16614691 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (LC) 250 mg
Number of subjects: 70
Study 16614691 — intervention group
Group type: COMPARATOR
Intervention: Naproxen sodium (NS) 550 mg
Number of subjects: 70
Study 16614691 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine clonixinate (LC)
Number of subjects: 70
Study 16614691 — intervention group
Group type: COMPARATOR
Intervention: Naproxen sodium (NS)
Number of subjects: 70
Study 12638395 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg single dose
Number of subjects: 36
Study 12638395 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg multiple doses (once daily for 10 days)
Number of subjects: 36
Study 12638395 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg with high-fat meal
Number of subjects: 36
Study 12638395 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 36
Study 10071726 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine 50 mg/day
Number of subjects: 17
Study 10071726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 7497662 — intervention group
Group type: EXPERIMENTAL
Intervention: Patella resurfaced
Number of subjects: 100
Study 7497662 — intervention group
Group type: COMPARATOR
Intervention: Not resurfaced
Number of subjects: 100
Study 1791772 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (walking on a treadmill 3 times per week for 20 min at 70% of maximum heart rate)
Number of subjects: 16
Study 1791772 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 16
Study 7112816 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheters changed monthly as well as for infection and/or obstruction
Number of subjects: 17
Study 7112816 — intervention group
Group type: COMPARATOR
Intervention: Catheters changed only for infection and/or obstruction
Number of subjects: 17
Study 30515573 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based reminiscence therapy (TBR)
Number of subjects: 135
Study 30515573 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support (TS)
Number of subjects: 135
Study 30515573 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 135
Study 28742260 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal individualized treatment rule using preference elicitation questionnaire and item response theory
Number of subjects: 0
Study 28742260 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 0
Study 26733563 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K3 acupuncture point injection
Number of subjects: 80
Study 26733563 — intervention group
Group type: COMPARATOR
Intervention: Saline acupuncture point injection
Number of subjects: 80
Study 26733563 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K3 deep muscle injection
Number of subjects: 80
Study 24969551 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (diet M)
Number of subjects: 391
Study 24969551 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyunsaturated fat hypocaloric diet (diet P)
Number of subjects: 391
Study 24969551 — intervention group
Group type: EXPERIMENTAL
Intervention: High polyunsaturated fat hypocaloric diet (diet P) in wild genotype
Number of subjects: 391
Study 24969551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets in both genotypes
Number of subjects: 391
Study 24969551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 391
Study 22431426 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 0
Study 19158211 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg folic acid daily for 30 weeks
Number of subjects: 40
Study 19158211 — intervention group
Group type: COMPARATOR
Intervention: 1.1 mg folic acid daily for 30 weeks
Number of subjects: 40
Study 17194818 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil for six months
Number of subjects: 12
Study 17194818 — intervention group
Group type: COMPARATOR
Intervention: Control group (FTD patients not receiving donepezil)
Number of subjects: 12
Study 15101069 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-ROM cognitive-behavioral self-help treatment (8 sessions)
Number of subjects: 60